首页 | 官方网站   微博 | 高级检索  
     

散发性胆囊癌nm23-H1基因遗传不稳定性与错配修复基因hMLH1和hMSH2蛋白表达的研究
引用本文:张国强;,张永奎;,卢海英;,李继承;.散发性胆囊癌nm23-H1基因遗传不稳定性与错配修复基因hMLH1和hMSH2蛋白表达的研究[J].中国病理生理杂志,2007,23(11):2179-2184.
作者姓名:张国强;  张永奎;  卢海英;  李继承;
作者单位:1舟山市人民医院,浙江 定海 316004;2浙江海洋学院医学院,浙江 杭州 310031;3浙江大学细胞生物学研究所,浙江 杭州 310031
基金项目:基金项目:舟山市医学科研基金资助项目
摘    要:目的: 研究人类17号染色体D17S396位点微卫星不稳定性和杂合性缺失,对nm23-H1蛋白表达的影响,同时检测错配修复基因hMLH1和hMSH2蛋白的表达,为揭示nm23-H1基因、hMLH1和hMSH2基因与肿瘤发生和转移机制提供实验依据。方法: 采用石蜡包埋组织抽提DNA、PCR-SSCP、常规银染、Envision免疫组织化学等方法,对50例胆囊癌及其相应的正常组织,进行D17S396位点MSI、LOH的检测和nm23-H1、hMLH1和hMSH2蛋白表达研究。结果: ①原发性胆囊癌D17S396位点遗传不稳定发生率为42.55%,LOH的发生率与肿瘤组织分化程度差异显著(P <0.05);在肝脏侵润和淋巴转移组高于无肝脏侵润和无淋巴转移组(P <0.01),在NevinⅣ+Ⅴ期高于Ⅰ+Ⅱ+Ⅲ期(P <0.01);而MSI发生率则相反;②nm23-H1蛋白阳性率为46.81%,在淋巴转移组低于无淋巴转移组(P <0.01);NevinⅣ+Ⅴ期低于Ⅰ+Ⅱ+Ⅲ期(P <0.05);③hMLH1和hMSH2蛋白阳性率分别为51.06%和42.55%,hMLH1蛋白表达在有无淋巴转移组和Nevin分期有显著差异(P <0.01),肝脏侵润组低于无肝脏侵润组(P <0.05);④MSI阳性组中hMLH1蛋白阳性率显著高于MSI阴性组(P <0.05)。LOH阳性组中nm23-H1和hMSH2蛋白阳性率显著低于LOH阴性组(P <0.05);⑤hMSH2蛋白阳性组中nm23-H1蛋白表达明显高于hMSH2蛋白阴性组(P<0.05)。结论:nm23-H1基因的遗传不稳定性可能是胆囊癌发生、发展的一个重要分子机制。nm23-H1基因的MSI和LOH,通过相互独立的途径调控胆囊癌的发生和转移。hMLH1/hMSH2表达异常可能是胆囊癌的早期分子事件。提高胆囊癌局部nm23-H1、hMLH1和hMSH2蛋白的表达,可减缓肿瘤的侵润转移并提高预后率。

关 键 词:胆囊肿瘤  基因  〖STBX〗nm23-H1  基因  hMLHI  基因  hMSH2  
文章编号:1000-4718(2007)11-2179-06
收稿时间:2006-4-20
修稿时间:2006-04-20

Study on genetic instability of nm23-H1 gene and expression of hMLH1,hMSH2 in sporadic gallbladder carcinoma
ZHANG Guo-qiang,ZHANG Yong-kui,LU Hai-ying,LI Ji-cheng.Study on genetic instability of nm23-H1 gene and expression of hMLH1,hMSH2 in sporadic gallbladder carcinoma[J].Chinese Journal of Pathophysiology,2007,23(11):2179-2184.
Authors:ZHANG Guo-qiang  ZHANG Yong-kui  LU Hai-ying  LI Ji-cheng
Affiliation:1Zhoushan Hospital,Dinghai 316004,China;2Zhejiang Ocean University Medical School,Dinghai 316004,China;3Institute of Cell Biology,Zhejiang University,Hangzhou 310031,China.E-mail: lijichen@zju.edu.cn
Abstract:AIM: To examine the MSI and LOH of locus D17S396 and their influence on the expression of nm23-H1 in gallbladder tumors,and to examine the protein expression of hMLH1/hMSH2,which may provide experimental evidence for the tumor occurrence and metastasis.METHODS: Techniques such as DNA extraction,CR-SSCP,ordinary silver stain were used to study MSI and LOH of locus D17S396.Envision IHC was used to assess the expression of nm23-H1 and hMLH1/hMSH2.RESULTS: ① The frequency of heredity instability of gallbladder carcinoma was 42.55%.The frequency of LOH in liver and lymph node metastasis cases and in stage Nevin IV and V was significantly higher than that without metastasis and stage I,II and III.However,the frequency of MSI showed contrary correlation with some clinicopathologic characteristics.② The expression of nm23-H1 was 46.81%.The case with lymph node metastasis and Nevin stage IV and V showed significantly lower expression than that without lymph node metastasis and stage I,II and III.③ The expressions of hMLH1 and hMSH2 were 51.06% and 42.55% respectively.hMLH1 in lymph node and liver metastasis cases and in stage Nevin IV and V were significantly lower than that without metastasis and in stage I,II and III.④ Positive frequency of hMLH1 in MSI positive group was higher than that in MSI negative group.The positive frequency of nm23-H1 and hMSH2 protein in LOH positive group was lower than that in negative group.CONCLUSION: The heredity instability of nm23-H1 gene may be implicated pathogenesis and progression of gallbladder carcinoma.Both MSI and LOH of nm23-H1 control the development of gallbladder carcinoma independently in different paths.Abnormal expression of hMLH1/hMSH2 may be a molecule marker in early stage of gallbladder carcinoma.
Keywords:Gallbladder neoplasms  Genes  nm23-H1  Genes  hMLH1  Genes  hMSH2
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号